Abstract:Background: Although the absolute number of postoperative positive lymph nodes has been considered as one of the most important predictors for the survival of rectal cancer patients, many researchers have suggested that the lymph node ratio (LNR) may have a better predictive effect. After chemoradiotherapy for rectal cancer, the number of lymph nodes harvested is often reduced, and the predictive value of the postoperative LNR after chemoradiotherapy is still unclear. We performed a retrospective study to analyze the survival predictive value of the LNR after preoperative chemoradiotherapy for rectal cancer. Methods: Between January 2012 and December 2014, a total of 133 patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy followed by total mesorectal excision were reviewed. According to the postoperative pathological LNR, patients were divided into 3 groups, i.e., LNR = 0, 0 < LNR <= 0.15, and 0.15 < LNR <= 1, and patients with lymph node metastasis were divided into 2 groups, and the overall survival (OS) and disease-free survival (DFS) of each group were analyzed and evaluated. Results: The median follow-up time of this study was 40 months, and the 5-year OS and DFS rates were 86.3% and 74.8% for the whole cohort, respectively. According to the postoperative pathological LNR, patients were divided into 3 groups, LNR = 0, 0 < LNR <= 0.15, 0.15 < LNR <= 1, the respective 5-year OS and DFS rates for the LNR 3 groups were 96.7%, 94.7% and 42.9% (P < 0.001) and 84.9%, 73%, and 30.7% (P < 0.001), respectively. Multivariate analysis revealed that only the LNR was the independent prognostic factor for these patients. For patients with lymph node metastasis, it was also revealed that only the LNR was an independent prognostic factor. Subgroup analysis demonstrated that there was a significant correlation between the LNR and patient survival both in the number of lymph nodes harvested, less than 12 and more than 12 subgroups (P < 0.05). Conclusion: The postoperative positive lymph node ratio (LNR) is an independent prognostic factor for patients with locally advanced rectal cancer who undergo preoperative chemoradiotherapy followed by total mesorectal excision. Both in the number of lymph nodes harvested less than 12 and more than 12 subgroups, the LNR is significantly correlated with patient survival.

Lymph node ratio and hematological parameters predict relapse-free survival in patients with high grade rectal neuroendocrine neoplasms after radical resection: a multicenter prognostic study

The Value of Lymph Node Ratio in the Prediction of Rectal Cancer Patient Survival after Preoperative Chemoradiotherapy.

Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indi-cators in gastric cancer patients after radical resection

Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection.

Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer

Number of Positive Lymph Nodes is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms

Prognostic value of lymph node ratio in survival of patients with locally advanced rectal cancer.

Prognostic Role of Lymphocyte-to-monocyte Ratio in Pancreatic Neuroendocrine Neoplasms

Prognostic Significance of the Metastatic Lymph Node Ratio in Node-Positive Rectal Cancer.

Examined Lymph Node Numbers Influence Prognosis in Rectal Cancer Treated with Neoadjuvant Therapy

Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy

Metastatic Lymph Node Ratio Can Further Stratify Prognosis in Rectal Cancer Patients Treated with Preoperative Radiotherapy: a Population-Based Analysis.

Prognostic Value Of Pretreatment Prognostic Nutritional Index Is Superior To Neutrophil To Lymphocyte Ratio For Survival In Patients With Neuroendocrine Tumors

Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation

Preoperative Lymphocyte-to-monocyte Ratio is a Superior Systemic Inflammation Marker to Predict Relapses in Patients with Pancreatic Neuroendocrine Neoplasms Following Curative Resections

Predictive value of positive lymph node ratio in patients with locally advanced gastric remnant cancer

Lymph node ratio prognosticates overall survival in patients with stage IV colorectal cancer

Different lymph node staging systems for predicting the prognosis of colorectal neuroendocrine neoplasms

Lymph node ratio predicts prognosis in patients with surgically resected invasive pancreatic cystic neoplasms

Preoperative Neutrophil-to-lymphocyte Ratio and Tumor-Related Factors to Predict Lymph Node Metastasis in Nonfunctioning Pancreatic Neuroendocrine Tumors.

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.